Podcasts about Laurence

Welcome To The Machine is a Pink Floyd tribute band from Singapore. With its members include: Lim Kiang as Bass, Noel Ong as Guitarist, Arinda as the front man, Laurence as the drummer, David as the Guitarist and Yuk Wong (not in around) as the keyboardist. So I has asked the million dollar question: Why Pink Floyd? It spiraled into a rabbit hole of favourite Pink Floyd songs and the theater aspect of Pink Floyd. Stories shared on how Welcome To The Machine got started. How the reception of Pink Floyd music in Singapore as compare to other countries such as Vietnam and India. Questions such as what they look out for during auditions and how the band stay together for close to a decade. The sacrifice and discipline that gels the band together. Kiang is an old veteran when it comes to the local music scene, the song that pushed Beatles off the charts and the story that make his previous band the straydogs as the rebel band in the 1960s. Oh yeah We do think there are dated songs from Pink Floyd and Laurence loves Tool as well.  Details of Welcome To The Machine concert: https://www.catch.sg/Event/Experience-The-Wall-from-the-inside-Welcome-To-The-Machine-brings-Pi-20250731131848

Carlos, Laurence, and Lana present the third session in their Vision Tribe Summit from February 2025.This conversation will help youDevelop a healthier relationship with money by understanding your personal money stories and how they affect your current attitudesCreate multiple income streams through a product pyramid approach rather than solely relying on selling your timePrice your services based on value rather than hourly rates, allowing you to better communicate the transformation you provide to clientsLinksJoin the conversation liveBecome a member of the Happy Startup SchoolJoin the next Vision 20/20 cohort

I love having Laurence on the show. he's done it a bunch of times before, but never solo. Will he prove that every time before this one he's been the dunce? Or will he somehow jag a whole bunch of questions that sit in his sweet spot? You'll have to listen to find out.Support this show http://supporter.acast.com/the-saturday-quiz. Hosted on Acast. See acast.com/privacy for more information.

Today we celebrate the Feast Day of St. Laurence, Deacon and Martyr for Christ. When the Roman emperor demanded the God's of Rome be worshipped by all, St. Laurence and the Christians in Rome refused to bow to idolatry. There is no greater love than to lay down one's life for a friend. Today we look at the testimony of the life of St. Laurence; a testimony of love for His Lord as he would sacrifice his life for the love of His Savior.

Laurence took an impromptu trip to Kansas City to visit the Negro Leagues Museum AND catch a White Sox game. He enjoyed it and thinks you would too. Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Laurence shares book report on Seth Wickersham's new 'American Kings' full 1148 Thu, 21 Aug 2025 00:08:16 +0000 sAQllwqvY2x6btMTigi5WWXvRHBy70sV sports Spiegel & Holmes Show sports Laurence shares book report on Seth Wickersham's new 'American Kings' Matt Spiegel and Laurence Holmes bring you Chicago sports talk with great opinions, guests and fun. Join Spiegel and Holmes as they discuss the Bears, Blackhawks, Bulls, Cubs and White Sox and delve into the biggest sports storylines of the day. Recurring guests include Bears cornerback Jaylon Johnson, former Bears coach Dave Wannstedt, former Bears center Olin Kreutz, Cubs manager Craig Counsell, Cubs second baseman Nico Hoerner and MLB Network personality Jon Morosi. Catch the show live Monday through Friday (2 p.m. - 6 p.m. CT) on 670 The Score, the exclusive audio home of the Cubs and the Bulls, or on the Audacy app. © 2025 Audacy, Inc. Sports False https://player.amperwav

In this episode, Lex speaks with Ravi Adusumilli - President and GM of the Americas at Airwallex. Ravi and Lex discuss how Airwallex has evolved into a global financial platform by offering businesses an integrated suite of cross-border payments, treasury, and banking services. Founded in 2015, Airwallex now supports 150,000 customers, processes $130 billion in annualized volume (up 73% YoY), and projects a $1 billion revenue run rate by year-end.The company's success stems from its end-to-end infrastructure, homegrown payment rails, and multi-product strategy, with 80% of revenue now coming from customers using more than one product. Airwallex differentiates itself by focusing on global-first B2B use cases and building regional autonomy alongside centralized infrastructure. While not prioritizing stablecoins today, the company is exploring AI-driven financial operations and aims to reach $1 trillion in transaction volume by 2030. NOTABLE DISCUSSION POINTS:Airwallex's Infrastructure: Proprietary Global Payment NetworkAirwallex operates a proprietary global payment infrastructure that processes 95% of its $130 billion in annualized transaction volume. The company has developed its own technology and regulatory framework in partnership with over 60 banks worldwide. This approach reduces dependence on legacy systems such as SWIFT and supports greater control over transaction speed, cost, and compliance.Expansion Through Multi-Product OfferingAirwallex has expanded its services beyond cross-border payments to include card issuance, spend management, treasury functions, and merchant acquiring. According to company data, 80% of revenue is generated from customers using multiple products. Payments now account for 70% of net revenue and are growing at three times the rate year over year.Decentralized Go-To-Market StructureAirwallex employs a regional management model, with General Managers responsible for performance and operations in specific geographies. This structure is supported by centralized functions such as product development, compliance, and engineering. With 1,700 employees in 26 offices, the company uses this hybrid model to manage growth and adapt to local regulatory environments across multiple regions, including Latin America and Asia-Pacific. TOPICSAirwallex, Stripe, Brex, Rippling, Shopify, Pinterest, Visa, fintech, global payments, e-commerce, cross-border transactions, paytech, embedded payments, CFO stack, stablecoins, AI ABOUT THE FINTECH BLUEPRINT

Dr. Sumanta (Monty) Pal and Dr. Arielle Elkrief discuss the clinical relevance of the gut microbiome in cancer immunotherapy and the importance of antibiotic stewardship, as well as interventions currently being explored to treat gut dysbiosis and optimize immunotherapy response. TRANSCRIPT Dr. Sumanta (Monty) Pal: Hi everyone, I'm Dr. Monty Pal, welcoming you to the ASCO Daily News Podcast. I'm a medical oncologist. I'm a professor and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles.  Today we're here to discuss one of my favorite topics, which is the gut microbiome. It's almost hard to avoid the gut microbiome nowadays if you look at medical literature within oncology. It's an emerging phenomenon, but there are a couple of individuals that I would really define as pioneers in the field. And one of them is actually with me today, Dr. Arielle Elkrief, to discuss the clinical relevance of the gut microbiome, particularly amongst patients receiving immunotherapy, although I imagine our conversation today will take many twists and turns. Arielle is an assistant professor and clinician scientist in the Department of Oncology at the University of Montreal, and she is co-director of the CHUM Microbiome Center there.  FYI for the listeners, we have our full disclosures in the transcript of this episode.  Arielle, thank you so much for joining us today. Dr. Arielle Elkrief: Thanks so much, Monty. This is going to be amazing. Dr. Sumanta (Monty) Pal: Well, I have to tell you what sort of inspired me to bring you on as a guest. It was one of many things, but it was this really terrific ASCO Educational [Book] article that you wrote. Now, I have to tell you, I've read all the articles sort of cover to cover in the book, and they're always a wonderful primer, so if our audience is studying for board research or something of that sort, it's a terrific resource to go through. I have to tell you, this piece on the gut microbiome that you wrote is nothing short of a masterpiece. If you read this cover to cover, it's actually going to give you, I think, a sense of the current state and future state of the field. I wanted to start by just sort of beginning with sort of the origin story for a lot of this, which is this association between the gut microbiome and immunotherapy response. This takes us back several years to this pivotal series of papers in Science. Maybe you could walk our audience through that. Dr. Arielle Elkrief: Absolutely. Well, thank you so much for your kind words about the ASCO [Educational] Book. It was a team effort with a lot of key opinion leaders in the field, so I'm really glad to learn that you've liked it.  Moving backwards in terms of how we came to understand that the gut microbiome is essential to priming a response to cancer immunotherapy actually goes back to 2015 and seminal papers that looked at what happens when we take mice that are germ-free mice that have never been exposed to a microbiome. These are mice that are born by cesarean section and essentially live in a bubble. And when we give those mice tumors and treat them, in the first papers with anti-CTLA-4 treatment, we realized that these antibodies don't work at all. And that was the first observation that the presence of a gut microbiome was essential to mounting an anti-cancer immune response. When we supplemented those same mice with beneficial bacteria or feces from responder patients, we were able to restore the response to immunotherapy. And so those were really the first preclinical observations that made us understand the critical role of the microbiome in immunotherapy response. Moving a little bit in the future, we examined the fecal microbiome composition using shotgun metagenomic sequencing in different cohorts of patients with solid tumors, namely lung cancers, kidney cancers, and also skin tumors like melanoma, and found that patients who responded to immunotherapy had a distinct microbiome that was characterized by beneficial bacteria compared to patients who experienced resistance to immunotherapy that had a dysbiotic or diseased microbiome. Dr. Sumanta (Monty) Pal: So, you know, it's interesting, these techniques that we're using to sequence the gut, they're a little bit different. So I wonder if you can give the audience a quick primer on these techniques that you're so well versed in, shotgun metagenomic sequencing, 16S rRNA sequencing. If you had to describe this in 30 seconds, which is a tall task, how would you do that? Dr. Arielle Elkrief: That's a tall task. Much of what we know about the microbiome initially came from a technique called 16S rRNA sequencing. This is a technique that amplifies the 16S region and basically tells you at the genus level what's going on at the level of bacterial composition. This technique is fast, relatively cheap, and can be performed on a laptop computer, which is excellent. The problem is that it's prone to a lot of technical variations. Different primers might give you different results, and you're really limited at the genus resolution. You can't get a good resolution in terms of species, and we're learning that different species from the same genus might have different physiological properties, and the same thing goes at the strain level. So when we really zone in and look at inter-species changes, we're seeing that these actually have specific functions in the host. So that brings us to metagenomic sequencing, which is a whole genome sequencing, next-generation sequencing based method that looks at the whole composition and gives you information not only on bacteria, but you might also get fungal and viral properties. You can zoom in on the strain level. You can also get functional output, so we can examine what the metabolic properties of specific species or strains might look like. The negative aspects of shotgun metagenomic sequencing is that it takes a lot of computational power in order to analyze the results and it might take a little bit longer. And certainly, within the clinical setting, not something that's feasible yet.  And that brings us to more novel point-of-care biomarker tools that we've collaborated in developing along with Dr. Laurence Zitvogel and Dr. Lisa Derosa at Gustave Roussy, that learning from the shotgun metagenomics results designed a probe using quantitative PCR which looks for this specific bacteria we know to be important and developed a ratio of harmful bacteria to beneficial bacteria. This is called the TOPOSCORE, and it actually is able to predict quite nicely the response to immunotherapy using a stool sample and a really good turnaround time of almost 72 hours. Dr. Sumanta (Monty) Pal: That was a perfect overview and a lot of information in a short amount of time. It also makes you take out your high school biology textbooks, doesn't it, to understand that the bacterial ribosome, right, is a different size and shape, and that's what we're sequencing here. But these techniques I think are incredibly important, and I'm glad you actually discussed this, this RT-PCR based strategy of calculating the TOPOSCORE. It lends itself to this phenomenon of dysbiosis, and I think for our audience, that's going to be an important term to understand as time goes on. There's the normal healthy gut and then there's this phenomenon of dysbiosis, which is, I guess, simply put, an unhealthy gut. But tell us about, you know, how often you see dysbiosis in a cancer patient, maybe versus a normal healthy adult. Dr. Arielle Elkrief: So, I think we can split up your question into two parts. One is we know from cohort studies and population level-based studies that the microbiome of patients with cancer is distinct from healthy patients or healthy people. And we know that because of the global composition. We also think that there are diversity metrics that lend themselves to being described as dysbiotic. But we do know that the microbiome of people with cancer is distinct from healthy volunteers. That's the first point.  In terms of how frequently dysbiosis occurs in patients with cancer, it's not very well defined. We know that even among healthy people, there is a certain level of dysbiosis. Laurence in her talk mentioned that to be about 10% to 20%. And the other fascinating component is that when we're thinking about dysbiosis and the cancer associated microbiome, in terms of the species that are enriched, it's quite striking that a lot of these dysbiotic or negative bacteria are also found to be enriched in patients with metabolic disease, like cardiovascular disease, for example. And so it's unclear if dysbiosis is the cause or consequence, but there definitely seems to be a general pattern of disease when looking at the microbiome compared to healthy people. Dr. Sumanta (Monty) Pal: That's interesting. So, I'll tell you, my second favorite portion of your article, and I'll tell you my favorite portion as well in the context of this podcast, but my second favorite part was the section around antibiotic stewardship. You know, the utilization of antibiotics in a very pragmatic fashion amongst our patients. Can you describe why that's so critical in the context of the microbiome? Dr. Arielle Elkrief: Antibiotics can disrupt the gut microbiome composition. We know this from mouse studies, but also cohort studies of patients that are exposed to antibiotics. And most importantly, we know that patients who are exposed to antibiotics, either before or during the immunotherapy period, have significantly worse progression-free survival and overall survival to immunotherapy. And this is true for immunotherapy in the monotherapy setting, but also when combined with chemotherapy. What's striking is that when we look at patients who are just treated with chemotherapy, we don't see the negative outcome of antibiotics on outcome and progression-free survival and overall survival, suggesting that the negative impact of antibiotics on outcomes is really specific to immunotherapy backbones. The other important point is that this negative signal is maintained even after adjusting for standard prognostic variables in the specific malignancies that we're looking at. And then most importantly, at the mechanistic level, we were able to actually pinpoint the mechanism behind this antibiotic related dysbiosis. And we see this with a bloom of negative bacteria which induces a loss of MAd-CAM, which is an endothelial gut checkpoint immune marker, and that causes an efflux of immunosuppressive T cells, which are usually in the gut, to go straight into the tumor where they make the tumor unamenable to an immunotherapy response. And so now we finally have the mechanism as to why antibiotics are harmful and why we need to practice antibiotic stewardship. Dr. Sumanta (Monty) Pal: And just to be clear for the audience, I mean, if a patient needs antibiotics, they need antibiotics. But perhaps it just suggests that, and we have, I suppose, this predilection as oncologists, just for the minor cold or cough or what have you, we maybe should be a little bit more cognizant of whether or not antibiotics are truly necessary. Is that fair? Dr. Arielle Elkrief: Absolutely. So what we're advocating for is antibiotic stewardship, and this is the clear recommendation that we can make. So that means confirming a bacterial infection. If it's there and antibiotics are indicated, to choose the most narrow spectrum for the shortest course and constantly re-evaluate the indication of antibiotics. And of course, we need to work with our colleagues in infectious diseases who've done incredible work in antibiotic stewardship. And all along this process we also need to be mindful of other medications and polypharmacy, such as proton pump inhibitors or narcotics, for example, we think that these other medications which are frequently prescribed in our cancer population can also potentially have negative impacts on the microbiome and immunotherapy response. Dr. Sumanta (Monty) Pal: I think that's a terrific summary and big guidance for the audience.  I promised you I'd tell you my favorite part of your article, and this is this huge table. I think the table is two and a half pages long, if I remember correctly, but it's an awesome table, and I highly recommend our audience to check this out. It lists literally every therapeutic trial for the microbiome under the sun. And so it begins with the approach of fecal microbiota transplant, which I'm going to ask you to tell us about in a second, but it also hinges on a lot of really cool sort of novel therapies, live bacterial products, mixes of different microbial products. Maybe take us through this whole approach of FMT (fecal microbiota transplantation). I actually wasn't aware of the dozens of trials that you listed there in this space. It seems like it's a very active area of research. Dr. Arielle Elkrief: Definitely. So, as you alluded to, FMT or fecal microbiota transplantation is the most well studied and direct way to modify the patient's microbiome. This technique aims to replace the patient's dysbiotic microbiome with that of a healthy microbiome, either from a healthy donor volunteer that's been heavily screened, or from a patient who experienced response to immunotherapy. And, as three landmark studies so far that have been published demonstrated the potential of FMT to reduce primary resistance or secondary resistance to immunotherapy, and this has been in melanoma.  We also recently reported on the results of our FMT-LUMINate trial, which looked at patients with lung cancer and melanoma. Once again, FMT, when combined with immunotherapy was safe and led to a higher proportion of responses than we would normally expect.  We're now also looking at randomized trials that have come out. So the first being the TACITO trial in kidney cancer, which compared FMT plus pembrolizumab and axitinib to placebo in patients with RCC, and again, FMT was safe and feasible and also led to an increased progression-free survival at one year, meeting the study's primary endpoint.  And so, so far, there's a wealth of data really showing the promise of FMT when combined with immunotherapy, and we're now in the process of conducting larger randomized trials, including in melanoma with the CCTG (Canada Cancer Trials Group) in our ME17 or Canbiome2 trial, where we're going to be enrolling 128 patients with metastatic melanoma to receive FMT and standard of care immunotherapy compared to standard of care immunotherapy alone. Dr. Sumanta (Monty) Pal: You're very humble, so I've got to highlight for our audience. This was a mega grant that Arielle received to fund really the largest prospective exploration of FMT that will exist to date. So I'm really excited about that. I wish this was something we could participate in stateside.  Before we jump into the other approach, which is live bacterial products and mixes thereof, where do you see FMT going? I think that one of the perceived challenges with FMT is that it's hard to implement, right? You need to have a really robust framework when it comes to gastroenterology, the preparation's challenging. Is there a way to envision FMT use being more generalized? Dr. Arielle Elkrief: Those are great questions. So we're lucky in Canada to work with pioneers in FMT, Michael Silverman, Saman Maleki, and John Lenehan in London, Ontario, who had this really robust FMT healthy donor screening program, which literally screens for every pathogen under the sun, and we haven't had any problems with feasibility or implementing FMT in Canada. But I think that once we're going to hopefully start doing larger scale, randomized phase three studies, that we might run into problems with scalability. And I think also with regards to reproducibility, and that's the feedback that we're getting from some regulatory authorities, especially at the level of the FDA, where there are some concerns around inter- and intra-donor variability because, of course, we can't guarantee that every fecal sample is going to be the same. So that has really pushed the field to think about other strategies, such as live biotherapeutic products which take modified FMT or bacteria from stools from either healthy donors or from responder patients and basically turn them into drugs that are regulated as drugs and can then be studied in the context of investigational new drugs or products. Dr. Sumanta (Monty) Pal: I like this and, you know, I do think that there's a future for it. We just have to kind of put our heads together and figure out how to get over all of these logistical hurdles, but, you know, I agree, I think your group and others have demonstrated, especially with this trial that you're fanning out all throughout Canada, that it can potentially be done.  This is a topic that could probably go on for another couple of hours, right, especially based on the size of the table that you put together in this brilliant article, but tell us about live bacterial products or LBPs, as we call them these days. What's the current status, what's the future there? And maybe I'll give you less than two minutes here, although again, I realize it's a two-hour topic. Dr. Arielle Elkrief: You're probably better suited to speak about that because you've been one of the pioneers in terms of this. So we can think about LBPs in terms of single strain organisms, like CBM588 for an example, which your group did some amazing work in showing that, in a randomized setting, that this led to better responses than we would expect compared to just work with controls. We also know that LBPs can have multiple strains, up to 30. We're collaborating with a company called Cannabis Bioscience that is actually working on much larger communities of consortia. And so we're really excited about the direction that that's taking in terms of taking these LBPs and developing them from the drug perspective. In addition to LBPs, we know that there are other ways that we can change the microbiome, notably prebiotics, which are compounds which can have a beneficial impact on the microbiome. And one of these is camu camu, which I know your group is leading a clinical trial looking at camu camu and kidney cancer, and we're excited to see how that compares to FMT or LBPs, because that might be a potentially scalable alternative. Dr. Sumanta (Monty) Pal: That's awesome. What a terrific overview, and that was less than two minutes. I don't know how you did it. That's terrific.  Arielle, this has been such an insightful conversation. I just want to thank you for, again, a terrific article in the ASCO Educational Book. I highly recommend all of our listeners to go there and check it out, and also for sharing all these terrific insights on the podcast today. Dr. Arielle Elkrief: Thank you so much, Monty. Dr. Sumanta (Monty) Pal: And thanks to our listeners, too. If you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Thanks, everyone. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:    Dr. Sumanta (Monty) Pal  @montypal Dr. Arielle Elkrief Follow ASCO on social media:     @ASCO on Twitter    ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Sumanta (Monty) Pal:   Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview  Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical  Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis  Dr. Arielle Elkrief: Honoraria: AstraZenica, Bristol-Myers Squibb, Merck, EMD Serono Consulting or Advisory Role: Bristol-Myers Squibb Research Funding (Inst.): Kanvas Bioscience, AstraZeneca, Merck Other Relationship: Royal College of Surgeons and Physicians of Canada, Cedar's Cancer Center (Henry R. Shibata Fellowship), Canadian Institutes of Health Research (CIHR)

In this episode, Dr. Daina Parent, ND, sits down with Laurence Katsaras—Naturopath, Acupuncturist, and classically trained Western Herbalist—for a deep dive into incretin hormones, especially GLP-1's and their far-reaching effects on the body. They discuss the interconnected web of health in which all physiological pathways work together, and how GLP-1 medications can distort this web leading to unintended effects elsewhere. They highlight clinical takeaways for keeping the web strong through hormone balance, gut health, herbs, diet, and lifestyle. They explore the pros and cons of GLP-1 receptor agonist medications, herbal and lifestyle recommendations to help manage side effects, and natural approaches that support the body's own ability to regulate these pathways. Laurence also shares insights from his 20 years in the natural medicine industry as a clinician, researcher, and educator. A sought-after speaker in the naturopathic and complementary medicine field across Australia and New Zealand, he is known for translating emerging research into practical, actionable strategies for clinical practice. Don't forget to follow and like our podcast channel to stay up-to-date on upcoming podcast episodes. Highlights of the episode include: GLP-1 medication effects vs. the body's natural GLP-1 hormone activity Risks for women in perimenopause, menopause, and postmenopause: muscle loss and bone health impacts Herbal compounds that stimulate GLP-1 receptors naturally The complex web of health: restoring balance in interconnected physiological systems Broad benefits of bitter herbs on the gut microbiome as part of a holistic approach to metabolic health Podcast Summary 1:30 Defining incretin hormones, including GLP-1 (glucagon-like peptide-1) 5:06 Organs that are influenced by incretin hormones, and how are they affected 7:48 GLP-1 medication effects vs. the body's natural GLP-1 hormone activity 8:53 Side effects of GLP-1 receptor agonist medications 11:00 Concerns about weight loss, muscle loss and rebound weight gain after discontinuing medication 15:30 Importance of continuing holistic diet and lifestyle habits after going off medications 18:20 Risks for women in perimenopause, menopause, and postmenopause: muscle loss and bone health impacts 20:07 Herbal compounds that stimulate GLP-1 receptors naturally—gentle, holistic alternatives without dramatic or rapid changes 29:00 How bitter herbs and foods stimulate incretin hormone production naturally 30:30 Herbs with metabolic benefits and that support GLP-1 function 32:25 Is long-term GLP-1 medication use sustainable considering side effects and costs? Harnessing the body's innate ability to rebalance 33:30 The complex web of health: restoring balance in interconnected physiological systems 36:22 Discontinuation rates of GLP-1 medications: potential for combining herbal approaches with medication 39:00 Herbal safety: choosing the right herb for the right person, only when truly needed 41:14 Broad benefits of bitter herbs on the gut microbiome as part of a holistic approach to metabolic health 47:10 The “interconnected web of health”—how a single strand impacts the whole system 49:20 Clinical guidance for supporting patients considering or currently taking GLP-1 medications

In this episode of The Widow Podcast, I talk with author and campaigner Laurence Carter about his powerful journey through grief after losing his wife, Melitta, to stage 4 cervical cancer in 2015. Laurence shares their love story, Melitta's diagnosis, and the long goodbye they faced together as a family. He opens up about his year-long walk around the coast of England and Wales, a challenge that raised awareness of cervical cancer, encouraged women to attend smear tests, and helped him navigate life after loss. We discuss: Coping with the death of a spouse after a long illness The emotional and physical impact of grief How walking, nature, and connection helped Laurence heal Stories from strangers he met along the way Why listening without trying to fix can be the greatest gift Finding love again after bereavement If you or someone you know has experienced the loss of a partner or wants to better understand grief recovery, this episode offers comfort, hope, and inspiration. Find out more about Laurence on his site, including where to buy copies of his wonderful book. https://laurencecarter.com For More Support: The Widows Membership: karensutton.co.uk/the-widow-membership Coaching and retreats: karensutton.co.uk

Laurence talks about two of your favorite subjects: Bears training camp and coverage of Caleb Williams.Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

He was the pagan jailkeeper who guarded St Laurence (see August 10); seeing his prisoner's holiness and the wonders wrought by him, Hippolytus was convinced of the truth of the Faith and became a Christian. When St Laurence baptized him, he was granted a vision of heaven and said 'I see innocent souls in great joy.' He took Laurence into his own home, and his entire household were baptized, nineteen in all.   When St Laurence was martyred, Hippolytus retrieved his body by night and buried it. He was detected and brought before the Emperor Valerian on the third day after Laurence's death. Despite severe beatings he would not renounce his faith. The Emperor ordered that he be stripped and flayed but, standing naked before the emperor, Hippolytus said 'You have not stripped me, but have begun to clothe me.' Despite all torments, neither Hippolytus nor any of his household would deny Christ. All of his household were slain, one by one, before Hippolytus. Finally Hippolytus himself was bound behind a wild horse and dragged to death. Our Holy Mother the Empress Irene (Xenia in Monasticism) (12th c.) She was the pious wife of the Emperor John II Comnenus (reigned 1118-1143), but retired into monastic life. She founded the Monastery of the Pantokrator in Constantinople.

“Anfield is not the same anymore,” commentary legend Clive Tyldesley wrote on Substack in March, because “our relationship with our football heroes has changed…It's now up to them to give us something to get excited about.”But when I asked Liverpool fan and prodigious observer of the game Laurence McKenna whether he agreed with that diagnosis, he offered a different one: It's not the tourist fans making their pilgrimage to Anfield who've dented the famous atmosphere, and it's not necessarily some growing sense among those in attendance that they'll cheer when they're entertained. It's the ticket resale platforms, Laurence said, who are all too willing to fill up the home sections with away fans and change the makeup of the collective Anfield organism.For more on the deep history and changing dynamics of Liverpool's famous stadium, check our Cathedrals feature:https://www.thefootballweekend.com/p/liverpool-anfield-champions-league-night Hosted on Acast. See acast.com/privacy for more information.

Laurence & Spiegs break down a trade scenario for Bears backup QB Tyson Bagent.

Laurence Juber is an extraordinary, Superstar British guitarist and 2x Grammy winner. He played for three years with Paul McCartney in Wings, Paul's post-Beatles band in the ‘70s and ‘80s. His first project after graduating from college was working with George Martin, the Beatles' producer, on an album for Cleo Laine. He also worked with Charles Aznavour. He played on the soundtrack of the film “The Spy Who Loved Me”. He played on the soundtrack for TV shows like “Happy Days” and “Family Ties”. And he's had a long solo career. He's particularly known for his incredible acoustic guitar playing.He's recorded with Ringo, Rosemary Clooney, Buzzy Linhart, Belinda Carlisle, Barry Manilow, Harry Styles - and now with me! Laurence contributed a wonderful guitar solo on a new, as yet unreleased track of mine.My featured song is “The Fall Of Winter”, a collaboration with Jim Peterik, Tony Carey and Elliott Randall. Spotify link.------------------------------------------The Follow Your Dream Podcast:Top 1% of all podcasts with Listeners in 200 countries!Click here for All Episodes Click here for Guest List Click here for Guest Groupings Click here for Guest TestimonialsClick here to Subscribe Click here to receive our Email UpdatesClick here to Rate and Review the podcast—----------------------------------------CONNECT WITH LAURENCE:www.laurencejuber.com____________________ROBERT'S NEWEST ALBUM:“WHAT'S UP!” is Robert's new compilation album. Featuring 10 of his recent singles including all the ones listed below. Instrumentals and vocals. Jazz, Rock, Pop and Fusion. “My best work so far. (Robert)”CLICK HERE FOR THE OFFICIAL VIDEOCLICK HERE FOR ALL LINKS—----------------------------------------Audio production:Jimmy RavenscroftKymera Films Connect with the Follow Your Dream Podcast:Website - www.followyourdreampodcast.comEmail Robert - robert@followyourdreampodcast.com Follow Robert's band, Project Grand Slam, and his music:Website - www.projectgrandslam.comYouTubeSpotify MusicApple MusicEmail - pgs@projectgrandslam.com 

Lex chats with Matthew Le Merle - CEO of Blockchain Coinvestors, a leading blockchain and AI fund-of-funds. He reflects on the limitations of large institutions in adopting disruptive technologies and why he chose to back innovators over incumbents, using stablecoins as an example of asymmetric value creation. Le Merle explains his evolution from angel investor to institutional LP, highlighting the benefits of leveraging top-tier venture capitalists' expertise in inefficient early-stage markets. He outlines the psychological challenges of venture investing, where failures appear early and outsized wins often take a decade, contrasting this with the faster liquidity but higher existential risk in token markets. Finally, he critiques institutional allocators for over-relying on efficient markets, under-allocating to venture despite its role in driving future value, and positions his strategy as fully committed to early-stage blockchain and AI as the highest-returning segments. NOTABLE DISCUSSION POINTS:1. Innovation Threatens Incumbents, Benefits Disruptors: Major technological shifts, from the internet to blockchain and AI, create winners and losers. Incumbents often resist disruptive change because it threatens existing revenue models, while nimble startups and tech-first companies can rapidly capture new market opportunities.2. Venture Success Requires Navigating High Failure Rates: In early-stage investing, most portfolio companies will fail, often within the first 3–4 years. Returns are driven by a small number of outsized successes, usually via acquisitions rather than IPOs, requiring patience, resilience, and a disciplined investment strategy.3. Inefficient Markets Offer the Greatest Asymmetric Upside: Early-stage venture and emerging technologies like blockchain and AI are inefficient markets where superior access, insight, and execution can generate returns far above those available in traditional, efficient markets like public equities or bonds. TOPICSBlockchain Coinvestors, Band of Angels, AngelList, Blockchain Capital, Pantera, Sequoia, Andreessen, BlackRock, Fidelity, Blockchain, DeFi, Decentralized Finance, Investment, Venture Capital, Angel Investment, Fund of Funds ABOUT THE FINTECH BLUEPRINT

Our latest guest is Laurence Tham, who moved to Portugal from Australia 3 years ago. Laurence is the Portugal Chair of TIGER 2, hosting intimate, peer-focused discussions that go far beyond finance, touching on family, purpose, performance and personal legacy. Laurence is also an experienced speaker, frequently featured on podcasts and co-host of two of his shows.Amongst other things, he chats to Dylan about why he moved here, how he is enjoying the lifestyle and how Portugal has surprised him.FOLLOW OUR GUEST:Laurence on LinkedInLaurence on InstagramLaurence's website  ABOUT PORTUGAL THE SIMPLE LIFE PODCAST: "Portugal - The simple life”, an insider's perspective on Portugal. We already know about Portugal's fantastic weather, food and beaches. In this podcast, we go deeper to meet the people who make this country so wonderful. Dylan, who has made his life in Portugal, shares an insider's perspective on what makes Portugal the unique, beautiful and fantastic country it is. Join him and his guests weekly as they shed light on the incredible people, culture, history and lifestyle that make Portugal one of the world's best places to live! Don't forget to subscribe to our Podcast to receive more stories about living and moving to Portugal! ⭐ EXCLUSIVE FOR SUBSCRIBERS⭐ If you're looking to buy a home in Portugal, book a 30-minute call with Dylan here:BOOK A CALL There are only 5 slots available every week – EXCLUSIVE for our podcast subscribers! SPONSOR:Portugal Realty, a Leisure Launch group company, sponsors this episode. FOLLOW US:Portugal The Simple Life WebsitePortugal The Simple Life FacebookPortugal The Simple Life InstagramPortugal The Simple Life XPortugal The Simple Life YouTubeFOLLOW OUR HOST: Dylan Herholdt - Portugal The Simple Life Podcast - LinkedIn Dylan Herholdt - Facebook Dylan The Simple Life - Instagram If you'd like to get in touch or share your experience with Portugal, Dylan would love to hear from you! Email: ola@portugal-the-simple-life.com WhatsApp: (+351) 910 571 613

Carlos, Laurence, and Lana present the second session in their Vision Tribe Summit from February 2025.This discussion will help youShift from traditional marketing approaches that target everyone to creating deeper impact with those who truly resonate with your valuesDiscover why vulnerability in sharing your journey can be your greatest asset in building genuine community connectionsUnderstand how stories serve as "light for others to follow," providing guidance through shared experiences of challenges and transformationSee how the principle "People like us do things like this" creates powerful cultural bonds that transcend traditional marketing approachesGain practical frameworks for using stories not just to sell products but to mobilize action, inspire change, and create safe spaces for deeper workLearn the value of crafting "future stories" that invite co-creation and collaboration, even before your vision has fully materialisedLinksJoin the conversation liveBecome a member of the Happy Startup SchoolJoin the next Vision 20/20 cohort

Morning Prayer for Sunday, August 10, 2025 (The Ninth Sunday after Pentecost, or the Eighth Sunday after Trinity [Proper 14]; Laurence, Deacon and Martyr at Rome, 258).Psalm and Scripture readings (60-day Psalter):Psalms 99-1011 Samuel 29Romans 10⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to access the text for the Daily Office at DailyOffice2019.com.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to support The Daily Office Podcast with a one-time gift or a recurring donation.

Evening Prayer for Sunday, August 10, 2025 (Proper 14; Laurence, Deacon and Martyr at Rome, 258).Psalm and Scripture readings (60-day Psalter):Psalm 102Hosea 8John 11:1-44⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to access the text for the Daily Office at DailyOffice2019.com.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to support The Daily Office Podcast with a one-time gift or a recurring donation.

"This Saint, who was born in Spain, was the Archdeacon of the Church of Rome, caring for the sacred vessels of the Church and distributing money to the needy. About the year 257, a harsh persecution was raised up against the Christians by Valerian. Pope Sixtus, who was from Athens, was commanded to worship the idols, and refused; before his martyrdom by beheading, he committed to Laurence all the sacred vessels of the Church. When Laurence was arrested and brought before the Prefect, he was questioned concerning the treasures of the Church; he asked for three days' time to prepare them. He then proceeded to gather all the poor and needy, and presented them to the Prefect and said, "Behold the treasures of the Church." The Prefect became enraged at this and gave command that Laurence be racked, then scourged with scorpions (a whip furnished with sharp iron points — compare II Chron. 10:11), then stretched out on a red-hot iron grill. But the courageous athlete of Christ endured without groaning. After he had been burned on one side, he said, "My body is done on one side; turn me over on the other." And when this had taken place, the Martyr said to the tyrants, "My flesh is now well done, you may taste of it." And when he had said this, and had prayed for his slayers in imitation of Christ, he gave up his spirit on August 10, 258." (Great Horologion). His icon shows him stretched on the grill.

What Is Your God Given Vision? – By Laurence Torr God has a plan and future and a hope for each person that has turned their hearts to God, and God has a plan and a great adventure and future for you, yes you reading this right now. God has called you to high and a mighty calling, making you extra ordinary with  His power living on the inside of you to accomplish all and anything God has give you to do for Him. God gave Abraham, Moses, Jacob Joesph, Solomon, King David and many others a vision and direction and purpose, and a hope with great desires and an expected end. and God has His vision and direction and purpose and desires and hope and a future and an expected end for you too.   Give/ Honour God  https://www.paypal.com/paypalme/laurencetorr Visit Our Website http://www.graceloveandtruth.com/ Visit Our YouTube Channel Here http://www.youtube.com/laurencetorr

He that observes the Wind – By Laurence Torr Another new month and time goes quickly, and God is at work directing and guiding and showing us His heart and how we can live and move and have our being in Him more perfectly as we practise our faith in our daily living.  I was reminded of a scripture in Ecclesiastes 11:4 and was inspired to share what God was inspiring in me, what a great encouragement to begin this new month of August, enjoy and as you Listen.   Give/ Honour God  https://www.paypal.com/paypalme/laurencetorr Visit Our Website http://www.graceloveandtruth.com/ Visit Our YouTube Channel Here http://www.youtube.com/laurencetorr

Potential Power & Authority By Laurence Torr Your in the driver seat of your life, where do you want to be, what do you want to do? You Call it, you choose it. God made things very simple and easy for us. whatsoever you desire or call for when you pray and what you believe and speak will become. You got to believe and speak like it is already yours. God call those things which are not as though they were. what you believe in your heart and speak with your mouth will manifest in your life negative or positive. You truly are where you are today because of what you believe and says. what have you been calling? what have you been saying? if you don't like the results change what you believe and speak. This sharing is for you, enjoy as you listen.   Give/ Honour God  https://www.paypal.com/paypalme/laurencetorr Visit Our Website http://www.graceloveandtruth.com/ Visit Our YouTube Channel Here http://www.youtube.com/laurencetorr

Never Give Up On Your God Given Dream – By Laurence Torr Whatever season of life your in, stay focused in your pursuit of your God given dreams and desires that God has put into to your heart, No matter the circumstance as you stay faithful and focused on God, He will bring those dreams and desires to past.   Give/ Honour God  https://www.paypal.com/paypalme/laurencetorr Visit Our Website http://www.graceloveandtruth.com/ Visit Our YouTube Channel Here http://www.youtube.com/laurencetorr

durée : 00:59:21 - Le Souffle de la pensée - par : Géraldine Mosna-Savoye - La philosophe Laurence Devillairs nous parle d'un classique de la philosophie qui, avec son "je pense, donc je suis", continue d'influencer l'ensemble de la discipline : le "Discours de la Méthode" de René Descartes, qui nous enjoint à agir avec volonté et vivre avec passion. - réalisation : Nicolas Berger - invités : Laurence Devillairs Philosophe, enseignante à Paris 1 Panthéon Sorbonne

Laurence loved this movie. Let him tell you why!Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

durée : 02:00:12 - Les Matins d'été - par : Julie Gacon, Sarah Masson - . - réalisation : Sam Baquiast - invités : Ken Daimaru Historien des sciences et de la médecine et maître de conférences à Université Paris Cité.; Masatoshi Inoue Doctorant en histoire des sciences à l'EHESS; Régis Meyran Anthropologue, chercheur associé à l'université de Nice, a coordonné avec Laurence de Cock « Paniques identitaire », ed. du Croquant et auteur de l'ouvrage « Le mythe de l'identité nationale », ed. Berg International.; Jeanne Perrin Professeure de médecine et de biologie de la reproduction et du développement à l'université d'Aix-Marseille

durée : 00:09:12 - France Culture va plus loin (l'Invité(e) des Matins d'été) - par : Julie Gacon, Sarah Masson - Pour remonter aux origines de la folk, Régis Meyran nous propose un voyage depuis les champs de coton de l'Amérique esclavagiste, jusqu'aux mouvements syndicaux des années 1920 en lutte pour la justice sociale. Un symbole de contestation de l'ordre politique, social et racial américain. - réalisation : Sam Baquiast, Vivian Lecuivre - invités : Régis Meyran Anthropologue, chercheur associé à l'université de Nice, a coordonné avec Laurence de Cock « Paniques identitaire », ed. du Croquant et auteur de l'ouvrage « Le mythe de l'identité nationale », ed. Berg International.

Laurence continues to make the case that Charles Tillman deserves to be in the Hall of Fame. Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Matt Spiegel and Laurence listened to Bears head coach Ben Johnson further detail where he saw sloppiness in the team's practice Sunday.

In the final hour, Matt Spiegel and Laurence Holmes turned their attention back to the Bears, with Holmes sharing his observations and notes from visiting practice last week. After that, Cincinnati Enquirer writer Gordon Wittenmyer joined the show to preview the Cubs-Reds series, which begins Monday evening at Wrigley Field.

Laurence was at Bears practice last week and shares his notes.

Laurence spent the day at Halas Hall covering the Bears. Here's what he took away from the experienceSupport this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Rory McGowam is joined by Laurence Kemball-Cook, CEO & Founder of Pavegen. Laurence talks to Rory about how he has designed a system to convert our footsteps into electricity. With walkways popping up all over the UK and across the globe, could this be the solution to the energy crisis and a key tool in the fight against climate change? https://www.pavegen.com/  https://www.crowdcube.com/companies/pavegen2/pitches/qD9yNl?_gl=1*1jyl4zg*_gcl_au*MTM0MTM3MzY3Ny4xNzUzNzgwMjEy 

Carlos, Laurence, and Lana present the first session in their Vision Tribe Summit from February 2025.In this session they explore four key dimensions of success:Finding ways to earn while doing what you love rather than chasing wealth at the expense of fulfilmentPrioritising what genuinely energises you rather than constant multitasking driven by feelings of "not-enoughness"Surrounding yourself with people who energise you and share your valuesCreating ripple effects by simply being your authentic self rather than trying to change the world through effortLinksJoin the conversation liveBecome a member of the Happy Startup SchoolJoin the next Vision 20/20 cohort

Laurence rejoices about Dick Allen finally getting Baseball's Hall of Fame and explains the gatekeeping that kept Allen out, all this time. He gets a little help from Nancy Faust & Doug Glanville. Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

James Gunn is building a new DC and Laurence is pretty impressed with the first submission.Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Things haven't gone great for the Bears offense so far. Some of that is to be expected. Laurence wants to explain why it isn't happening as fast as anyone would like. Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

EVEN MORE about this episode!What if stress could be your doorway to enlightenment? Join us for an inspiring conversation with mindfulness pioneer Laurence Bibas, as she reveals how meditation can do more than just relax you—it can awaken your inner light. After a life-shifting loss, Laurence turned to mindfulness and Tibetan Buddhism, discovering a path to profound self-connection, joy, and spiritual empowerment.Together, we explore how tuning into the body's subtle signals can unlock emotional healing and lasting transformation. Learn how simple shifts in awareness, like using an “activation phrase,” can rewire your inner dialogue and break free from the pressures of perfection and self-judgment.If you're ready to move beyond coping and step into clarity, presence, and purpose—this episode is your gateway. Don't miss this soul-stirring journey into the power of mindfulness to heal, elevate, and liberate.Guest Biography:Laurence Bibas is a pioneer of Mindfulness-Based Stress Reduction in France, with over 25 years of experience in Tibetan meditation and other wisdom traditions. A passionate speaker and author of Manuel de Mindfulness and Ne s'attendre à rien, être prêt à tout, she shares an authentic and joyful path to self-awareness. Her latest book, The Great Return to Self, invites readers to reconnect with the deep beauty of their innate nature.Episode Chapters:(0:00:01) - Exploring Enlightenment and Joyful Scouting(0:15:10) - Discovering Mindfulness and Inner Peace(0:34:33) - Uncovering Inner Wisdom and Spiritual Growth(0:49:31) - Body Wisdom and Healing Meditation➡️Subscribe to Ask Julie Ryan YouTube➡️Subscribe to Ask Julie Ryan Español YouTube➡️Subscribe to Ask Julie Ryan Português YouTube➡️Subscribe to Ask Julie Ryan Deutsch YouTube➡️Subscribe to Ask Julie Ryan Français YouTube✏️Ask Julie a Question!

Lex chats with Harish Natarajan - Practice Manager, Financial Inclusion and Infrastructure, Finance, Competitiveness & Innovation at the World Bank, and Carlos Brandt - The Senior Advisor for Pix at the Central Bank of Brazil. Together they discuss the remarkable success of Pix, Brazil's real-time payment system, which now sees over 6 billion transactions per month and is used by more than 90% of the adult population and 80% of companies. Lex explores how Pix was created by the Central Bank of Brazil with strong public-private collaboration, backed by regulatory authority and supported by a co-creation model with stakeholders. Key to its adoption were a low-cost centralized infrastructure, clear branding, mandatory participation by large banks, and a robust national communication strategy. Globally, Pix is seen as a leading example of fast payment system deployment, driven by the central bank acting as a neutral coordinator and scheme owner. Lex also examines the technical architecture, built in-house by a surprisingly small team of 55–65 people, and how scalable infrastructure and extensibility have enabled rapid growth and innovation. NOTABLE DISCUSSION POINTS: 1. Pix achieved mass adoption through public-private co-creation and legal mandate:Pix now processes over 6 billion transactions per month, with 90% of Brazil's adult population and 80% of businesses actively using it. Its success stems from a strategic legal mandate in 2013 granting the Central Bank regulatory and operational authority over retail payments. The Central Bank then led a co-creation process involving both public and private stakeholders through the Pix Forum, fostering alignment, inclusivity, and strong network effects.2. A lean but powerful team built a nation-scale real-time payments system:The Pix infrastructure was built entirely in-house by a relatively small team, 30-40 people for the technical infrastructure layer and around 25 for the payment scheme layer. It operates 24/7 with real-time settlement and uses centralized infrastructure separate from Brazil's traditional large-value payment rails. This centralized, purpose-built architecture dramatically lowered costs and enabled rapid rollout.3. Strategic communication and mandated participation drove adoption at scale:The Central Bank led a national communication campaign to build trust, establish a strong brand identity, and educate the public. Simultaneously, it mandated major banks (with over 500,000 active accounts) to join Pix, triggering widespread voluntary adoption from smaller PSPs. The rollout included a restricted pilot phase and emphasized user-friendly features like QR codes and aliases to boost convenience and usage from day one. TOPICS Pix, Central Bank of Brazil, World Bank, Visa, Citibank, M-Pesa, Alipay, SPI, fintech, payments, PSP, API, Fast Payments, Payments Infrastructure, PayTech ABOUT THE FINTECH BLUEPRINT 

Laurence talks about winning The Athletic's poll for being the best sports radio host in Chicago. Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Jackie Hill Perry and Laurence Koo tackle some of the most pressing questions surrounding faith, sexuality, and discipleship. No small talk here—just honest answers about the reality of same-sex attraction, the cost of following Jesus, and the beauty of surrender. Whether you're a pastor, parent, friend, or someone personally navigating LGBT questions, this is a must-hear conversation. Guests: Jackie Hill Perry & Laurence Koo   Follow-up Resources: Become a monthly donor and get a free copy of Surrendered Sexuality! Or, buy your copy here. Follow Jackie Hill Perry at @jackiehillperry Follow Authentic Intimacy at @authenticintimacy  

The Bears got their second round picks signed. Laurence thinks all 3 will have a Deep Impact on the 25-26 Season and explains why. Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Should the city renew its contract with NASCAR? Laurence gives some pros and cons.Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Laurence and Jason react to Kalyn Kahler explaining that part of NFLPA Executive Director Lloyd Howell's pitch to getting elected in 2023 was explaining how he fought unions as a corporate executive.

Laurence delves into the contract extension for Bears GM Ryan Poles. Did it make sense to do it now? Let's chat about it. Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Laurence is back from Vegas with stories to tell about the Bulls and Summer League. Here's what he experienced. Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

The Cubs are 57-39 at the break. Here's what Laurence thinks is important in review.Support this podcast at — https://redcircle.com/house-of-l-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Who let the Fox out? Actor, activist and our friend Laurence Fox got married over the weekend and we are so happy for him and his beautiful bride, Elizabeth. You'll remember Laurence played Hunter Biden in our MY SON HUNTER movie. You can watch the movie in the link below. You can watch the podcast to see the happy couple and the celebrity dissidents who danced the night away at the wedding. Our special guest proves, once again, that Ireland is the most anti-semitic country in Europe. We have an exclusive interview with Jamie O'Mahony, the student who was assaulted by a professor for daring to ask a question and telling the truth about Israel. Listen to the shocking details that hit closer to home than you could imagine. Also on the show we have:Find out how Ryan Casey turned the tables on the legacy media when he dared tell the truth about his girlfriend's killer and foreign criminals in our midst. They tried to say he was inciting hate, and lost a defamation suit.And just when you thought Hollywood couldn't get any more transgressive, they actually shock you. Find out how Pixar/Disney tried to smuggle in a story about a gay 12-year-old in its kids movie, ELIO. You can also get Phelim's full thoughts on the subject in his Substack.An Australian woman was found guilty of poisoning her in-laws with death cap mushrooms, we also discuss another cautionary tale that solidifies our belief in store-bought, not home-grown mushrooms. Also, a journalist gets a very embarrassing lesson on why we shouldn't let AI do our homework.And Northern Ireland is giving out free cars for the disabled in its Motability scheme. You won't believe what counts as a disability, it includes the last people who should be behind the wheel. And we love hearing from you, so leave a comment wherever you get our content and we may read it on the show.Remember guys we are a 501(c)(3), please go to our website, unreportedstorysociety.com and give what you can so that we can keep bringing our show, and special projects to you. And did you know that you don't have to wait a week to get the scoop? Subscribe to our Stories.io substack where you get the news and views every day. Watch MY SON HUNTER here: https://unreportedstorysociety.com/my-son-hunter-the-hunter-biden-movie/Read Phelim's in-depth review of ELIO here: https://phelimmcaleer.substack.com/p/pixars-big-gay-disaster-will-disneyGo here to donate: https://unreportedstorysociety.com/ Substack link: https://phelimmcaleer.substack.com/